Phreesia (NYSE:PHR) Receives Buy Rating from Canaccord Genuity Group

Canaccord Genuity Group restated their buy rating on shares of Phreesia (NYSE:PHR – Free Report) in a research note issued to investors on Friday, Benzinga reports. They currently have a $46.00 target price on the stock. A number of other research firms have also issued reports on PHR. Stephens reaffirmed an overweight rating and set […]

Related Keywords

Canada ,United States ,Robertw Baird ,Michaelj Davidoff , ,Canaccord Genuity Group ,Securities Exchange Commission ,Tower Research Capital ,Phreesia Company Profile ,Keycorp ,Acadian Asset Management ,Phreesia Inc ,Bessemer Group Inc ,Free Report ,Moderate Buy ,Exchange Commission ,Asset Management ,Financial Advisors ,Research Capital ,Bessemer Group ,Get Free Report ,Its Phreesia Platform ,Phreesia Daily ,Phreesia ,Nyse Phr ,Phr ,Medical ,Reiterated Rating ,Canaccord Genuity Group Inc ,